180 mg WATSON 663
Pill imprint 180 mg WATSON 663 has been identified as Diltiazem hydrochloride CD 180 mg/24 hours.
Diltiazem is used in the treatment of high blood pressure; atrial fibrillation; supraventricular tachycardia; heart failure; atrial flutter (and more), and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy.
Diltiazem 180 mg/24 hours is not subject to the Controlled Substances Act.
See also related documents.
Diltiazem hydrochloride CD Images
- Imprint:
-
180 mg WATSON 663
- Strength:
- 180 mg/24 hours
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
Group IV antiarrhythmics - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
Advertisement
More Diltiazem Hydrochloride CD resources
- Diltiazem
- Diltiazem (Wolters Kluwer)
- Diltiazem 12-Hour Sustained-Release Capsules (Wolters Kluwer)
- Diltiazem 24-Hour Extended-Release Beads Capsules (Wolters Kluwer)
- Diltiazem 24-Hour Extended-Release Beads Tablets (Wolters Kluwer)
- Diltiazem 24-Hour Sustained-Release Beads Capsules (Wolters Kluwer)
- Diltiazem 24-Hour Sustained-Release Capsules (Wolters Kluwer)
- Diltiazem Immediate-Release Tablets (Wolters Kluwer)
- Dilt-CD (Cerner Multum)
- diltiazem (Cerner Multum)
- Dilt-CD (Micromedex) - Includes Dosage Information
- diltiazem (Micromedex) - Includes Dosage Information
- diltiazem Intravenous (Micromedex) - Includes Dosage Information
- Diltiazem Hydrochloride (AHFS DI)
- DILT-CD (FDA)
- Diltiazem (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
- Diltiazem Hydrochloride (Wolters Kluwer)
Search Again
